Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial
| Image |  |
|---|---|
| Description | scientific article published on 01 September 2018 |
| Author/s |
author: Hope Rugo Sara A Hurvitz Joanne L Blum Alison L Hannah |
| Publication date | September 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |